Pharmaceutical Industry

  • How Private Equity Cashed in on Medical Abortion

    The American effort to bring the French RU-486 medication to the domestic market made medical abortion much more widely accessible. But, in true American fashion, the involvement of private investors looking for profit also made it much more expensive—even more so after Dobbs.

  • With COVID, None of Us are Safe Until All of Us are Safe

    by Robert Brent Toplin

    Deference to the patent claims of pharmaceutical companies are slowing the urgently needed distribution of COVID vaccines to poorer nations. Residents of rich nations will pay a price as new, potentially dangerous variants like Omicron spread.